<![CDATA[Using Intrathecal Dendritic Cells for Leptomeningeal Disease From Breast Cancer]]>

Phase 1Intrathecal Dendritic Cell TherapyNeutral

AI Analysis

Summary

Peter Forsyth, MD, discusses a first-in-human trial of intrathecal dendritic cell therapy for treating leptomeningeal disease from breast cancer. The article provides clinical context for this early-stage investigational approach.

Clinical Trial Data

Phase

Importance:5/10

Sentiment:

0.00

dendritic cell therapyleptomeningeal diseasebreast cancerfirst-in-human trialintrathecal delivery

Related Companies

$TRAX

Read the original article

Published by Cancer Network on September 21, 2026 9:00 PM

Read Original